FDA Inspection
Albert Oriol Rocafiguera, MDAlbert Oriol Rocafiguera, MD – FDA Inspection, May 22, 2015
Record Details
This FDA Inspection record concerns Albert Oriol Rocafiguera, MD, with an inspection on May 22, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Albert Oriol Rocafiguera, MD
- Inspection Date
- May 22, 2015
- Product Type
- Drugs
View Company Profile
ID · d5d811ac-fc62-4c6e-80af-49bee8e26b6d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 930720
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Albert Oriol Rocafiguera, MD
2| Date | Classification | Office | Project area |
|---|---|---|---|
| December 5, 2025 | Not classified | Office of Inspections and Investigations | |
| February 22, 2024 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Albert Oriol Rocafiguera, MD
- FDA Inspection 1299372 - 2025-12-05
- FDA Inspection 1231776 - 2024-02-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.